CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
8.91
0.01 (0.11%)
At close: Sep 29, 2025, 3:57 PM
8.99
0.90%
After-hours: Sep 29, 2025, 07:22 PM EDT
0.11% (1D)
| Bid | 6.25 |
| Market Cap | 5.12M |
| Revenue (ttm) | 3.14K |
| Net Income (ttm) | -15.46M |
| EPS (ttm) | 2131.86 |
| PE Ratio (ttm) | n/a |
| Forward PE | -1.36 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.28 |
| Volume | 12,432 |
| Avg. Volume (20D) | 51,042 |
| Open | 9.00 |
| Previous Close | 8.90 |
| Day's Range | 8.77 - 9.00 |
| 52-Week Range | 4.93 - 222.00 |
| Beta | 0.64 |
| Ex-Dividend Date | n/a |
About CNSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-15.59%
CNS Pharmaceuticals shares are trading lower. The ...
Unlock content with
Pro Subscription
2 months ago
-10.7%
CNS Pharmaceuticals shares are trading lower after the company announced a 1-for-12 reverse split.
2 months ago · accessnewswire.com
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect SegmentHOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri...